Displaying 851 - 900 of 15022 results
Released Company Title Industry Topic
31 Jul 2024
17:45 CEST
GIMV Report of the Extraordinary General Shareholders’ Meeting 30202010 Asset Managers and Custodians Other subject
31 Jul 2024
08:05 CEST
TITAN CEMENT Résultats du premier semestre 2024 50101030 Cement Commercial results
31 Jul 2024
08:05 CEST
TITAN CEMENT First Half 2024 Results 50101030 Cement Commercial results
31 Jul 2024
07:31 CEST
VASTNED BELGIUM Vastned Belgium: Toepassing van artikel 7:97 WVV door de raad van bestuur van Vastned Belgium 35102045 Retail REITs Mergers, Acquiqitions, Transferts
31 Jul 2024
07:31 CEST
VASTNED BELGIUM Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium 35102045 Retail REITs Mergers, Acquiqitions, Transferts
31 Jul 2024
07:31 CEST
VASTNED BELGIUM Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium 35102045 Retail REITs Mergers, Acquiqitions, Transferts
31 Jul 2024
07:30 CEST
VASTNED BELGIUM Vastned Belgium publishes the agenda for the extraordinary general meeting of shareholders of September 25, 2024 35102045 Retail REITs General meeting / Board Meeting
31 Jul 2024
07:30 CEST
AEDIFICA Aedifica NV/SA: 2024 half year financial report 35102010 Health Care REITs Commercial results
31 Jul 2024
07:30 CEST
VASTNED BELGIUM Vastned Belgium maakt de agenda bekend voor de buitengewone algemene vergadering van aandeelhouders van 25 september 2024 35102045 Retail REITs General meeting / Board Meeting
31 Jul 2024
07:30 CEST
VASTNED BELGIUM Vastned Belgium publishes the agenda for the extraordinary general meeting of shareholders of September 25, 2024 35102045 Retail REITs General meeting / Board Meeting
31 Jul 2024
07:00 CEST
SOLVAY Solvay second quarter 2024 results 55201000 Chemicals: Diversified Corporate life
31 Jul 2024
07:00 CEST
MELEXIS Melexis Q2 2024 resultaten – Omzet van 245,7 miljoen EUR voor het tweede kwartaal 10102010 Semiconductors Corporate life
31 Jul 2024
07:00 CEST
MELEXIS Melexis Q2 2024 results – Second quarter sales of 245.7 million EUR 10102010 Semiconductors Corporate life
31 Jul 2024
07:00 CEST
ONTEX GROUP Strong H1 results leading to upward revision of full year outlook, with volume growth and cost transformation driving profitability up and leverage down further 45201020 Personal Products Income
31 Jul 2024
07:00 CEST
SOLVAY Résultats du deuxième trimestre 2024 55201000 Chemicals: Diversified Corporate life
31 Jul 2024
07:00 CEST
MELEXIS Melexis Q2 2024 résultats – Chiffre d'affaires de 245.7 millions d'euros au deuxième trimestre 10102010 Semiconductors Corporate life
31 Jul 2024
07:00 CEST
ONTEX GROUP Sterke resultaten in 1ste jaarhelft leiden tot opwaartse bijstelling van vooruitzichten, waarbij volumegroei en kostentransformatie de winstgevendheid opdrijven en de hefboomratio verder doen dalen 45201020 Personal Products Income
31 Jul 2024
07:00 CEST
SOLVAY Resultaten Solvay van het tweede kwartaal 2024 55201000 Chemicals: Diversified Corporate life
30 Jul 2024
18:00 CEST
VAN DE VELDE VAN DE VELDE : inkoop eigen aandelen 40204020 Clothing and Accessories Other subject
30 Jul 2024
18:00 CEST
VAN DE VELDE VAN DE VELDE : acquisition of treasury shares 40204020 Clothing and Accessories Other subject
30 Jul 2024
18:00 CEST
KBC KBC - Call notice to holders 30101010 Banks Legal
30 Jul 2024
08:33 CEST
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
30 Jul 2024
08:32 CEST
TITAN CEMENT Share buyback programme 50101030 Cement Other subject
30 Jul 2024
08:30 CEST
CIE BOIS SAUVAGE Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 22/07/2024 tot 26/07/2024 30202010 Asset Managers and Custodians Other subject
30 Jul 2024
08:30 CEST
CIE BOIS SAUVAGE Cie du Bois Sauvage: Buy back of own shares – week from 22/07/2024 to 26/07/2024 30202010 Asset Managers and Custodians Other subject
30 Jul 2024
08:30 CEST
CIE BOIS SAUVAGE Cie du Bois Sauvage : Rachat d’actions propres – semaine du 22/07/2024 au 26/07/2024 30202010 Asset Managers and Custodians Other subject
30 Jul 2024
08:00 CEST
KBC KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen 30101010 Banks Other subject
30 Jul 2024
08:00 CEST
KBC KBC Group: Update regarding the KBC Group share buyback programme 30101010 Banks Other subject
30 Jul 2024
08:00 CEST
KBC KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe 30101010 Banks Other subject
29 Jul 2024
22:30 CEST
NYXOAH SA Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 20102010 Medical Equipment Other subject
29 Jul 2024
22:30 CEST
NYXOAH SA Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre Et le Premier Semestre 2024 le 6 Août 2024 20102010 Medical Equipment Other subject
29 Jul 2024
18:07 CEST
GBL GBL - Transacties op GBL-aandelen 29-07-2024 30202000 Diversified Financial Services Other financial transaction
29 Jul 2024
18:06 CEST
GBL GBL - Transactions sur actions propres 29-07-2024 30202000 Diversified Financial Services Other financial transaction
29 Jul 2024
18:06 CEST
GBL GBL - Transactions on GBL shares 29-07-2024 30202000 Diversified Financial Services Other financial transaction
29 Jul 2024
17:45 CEST
SYENSQO Syensqo - Acquisition d'actions propres 55101000 Diversified Materials Change in Capital
29 Jul 2024
17:45 CEST
SYENSQO Syensqo - Verwerving van eigen aandelen 55101000 Diversified Materials Change in Capital
29 Jul 2024
17:45 CEST
SYENSQO Syensqo - Acquisition of own shares 55101000 Diversified Materials Change in Capital
29 Jul 2024
06:50 CEST
JENSEN-GROUP Inkoop eigen aandelen - wekelijkse update 50204000 Machinery: Industrial Other subject
29 Jul 2024
06:49 CEST
JENSEN-GROUP Share buyback – weekly update 50204000 Machinery: Industrial Other subject
26 Jul 2024
08:15 CEST
BEKAERT Bekaert - Update over de Liquiditeitsovereenkomst 55102010 Iron and Steel Legal
26 Jul 2024
08:15 CEST
BEKAERT Bekaert - Update on the Liquidity Agreement 55102010 Iron and Steel Legal
26 Jul 2024
08:15 CEST
BEKAERT Bekaert - Mise à jour relative au Contrat de liquidité 55102010 Iron and Steel Legal
26 Jul 2024
07:00 CEST
ACKERMANS V.HAAREN Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge 30202000 Diversified Financial Services Income
26 Jul 2024
07:00 CEST
UMICORE UMICORE: HALFJAARRESULTATEN 2024 55201020 Specialty Chemicals Income
26 Jul 2024
07:00 CEST
UMICORE UMICORE: HALF YEAR RESULTS 2024 55201020 Specialty Chemicals Income
26 Jul 2024
07:00 CEST
BEKAERT Bekaert: Résultats du premier semestre 2024 55102010 Iron and Steel Sales
26 Jul 2024
07:00 CEST
ACKERMANS V.HAAREN Ackermans & van Haaren leidt Serie B-financierings-ronde van 60 miljoen euro voor Confo Therapeutics, een Belgische biofarmaceutische onderneming 30202000 Diversified Financial Services Income
26 Jul 2024
07:00 CEST
ACKERMANS V.HAAREN Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company 30202000 Diversified Financial Services Income
26 Jul 2024
07:00 CEST
UMICORE UMICORE : RÉSULTATS DU PREMIER SEMESTRE 2024 55201020 Specialty Chemicals Income
26 Jul 2024
07:00 CEST
BEKAERT Bekaert: Halfjaarresultaten 2024 55102010 Iron and Steel Sales